KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Accumulated Expenses (2016 - 2025)

Charles River Laboratories International has reported Accumulated Expenses over the past 17 years, most recently at $270.1 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 50.53% year-over-year to $270.1 million; the TTM value through Dec 2025 reached $270.1 million, up 50.53%, while the annual FY2025 figure was $270.1 million, 50.53% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $270.1 million at Charles River Laboratories International, roughly flat from $269.7 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $270.1 million in Q4 2025 and troughed at $176.1 million in Q2 2023.
  • A 5-year average of $214.8 million and a median of $210.7 million in 2023 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: soared 58.74% in 2021 and later decreased 22.51% in 2023.
  • Year by year, Accumulated Expenses stood at $228.8 million in 2021, then fell by 13.86% to $197.1 million in 2022, then grew by 8.23% to $213.3 million in 2023, then fell by 15.88% to $179.4 million in 2024, then skyrocketed by 50.53% to $270.1 million in 2025.
  • Business Quant data shows Accumulated Expenses for CRL at $270.1 million in Q4 2025, $269.7 million in Q3 2025, and $227.5 million in Q2 2025.